Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

292
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
292
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

796
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
796
Antihypertensive Drugs: Thiazide-Class Diuretics01:15

Antihypertensive Drugs: Thiazide-Class Diuretics

2.1K
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
2.1K
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

445
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
445
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

406
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
406
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

629
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
629

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel markers of graft outcome in a cohort of kidney transplanted patients: a cohort observational study.

Journal of nephrology·2019
Same author

Should we really STOP treating patients with IgA nephropathy with steroids?

Physiology international·2018
Same author

Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases.

Journal of nephrology·2017
Same author

Synthetic pharmacotherapy for lupus nephritis.

Expert opinion on pharmacotherapy·2017
Same author

Predictors of renal survival in ANCA-associated vasculitis. Validation of a histopatological classification schema and review of the literature.

Clinical and experimental rheumatology·2015
Same author

Pregnancies in women receiving renal transplant for lupus nephritis: description of nine pregnancies and review of the literature.

Lupus·2015

Related Experiment Video

Updated: Mar 10, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

3.6K

Hydroxychloroquine in systemic lupus erythematosus (SLE).

C Ponticelli1, G Moroni2

  • 1a Nephrological Unit , Humanitas Clinical and Research Center , Rozzano (Milano) , Italy.

Expert Opinion on Drug Safety
|December 9, 2016
PubMed
Summary

Hydroxychloroquine (HCQ) is an effective and safe treatment for systemic lupus erythematosus (SLE), reducing flares and organ damage. It is also safe for pregnant women, though retinopathy risk requires monitoring.

Keywords:
Systemic lupus erythematosusantimalarial agentscutaneous lupushydroxychloroquinelupus flareslupus nephritisretinopathy

More Related Videos

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
05:39

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus

Published on: May 16, 2025

787
The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

18.8K

Related Experiment Videos

Last Updated: Mar 10, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

3.6K
Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
05:39

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus

Published on: May 16, 2025

787
The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

18.8K

Area of Science:

  • Rheumatology
  • Pharmacology

Background:

  • Hydroxychloroquine (HCQ) is an alkalinizing drug that increases lysosomal pH, impacting cellular functions.
  • HCQ is established as effective in managing autoimmune diseases like systemic lupus erythematosus (SLE).

Purpose of the Study:

  • To review the mechanisms of action, efficacy, and safety of HCQ in SLE management.
  • To evaluate HCQ's role in reducing disease activity, steroid dosage, organ damage, and thrombotic events.

Main Methods:

  • Literature review of HCQ's use in systemic lupus erythematosus.
  • Analysis of HCQ's pharmacological effects, clinical efficacy, and safety profile.

Main Results:

  • HCQ can decrease SLE flares, enable lower steroid doses, and reduce organ damage.
  • It may prevent thrombotic events associated with anti-phospholipid antibodies.
  • HCQ is generally safe, suitable for pregnant women, but necessitates monitoring for retinopathy.

Conclusions:

  • HCQ offers significant benefits for mild and severe SLE, including organ involvement and pregnancy.
  • Its low cost and favorable safety profile support broader clinical application.
  • Careful monitoring is essential to mitigate the risk of HCQ-induced retinopathy.